MRF Letter to the Editor Published in The New York Times

The Times published the Melanoma Research Foundation’s (MRF) response to Amy Harmon’s three part series, which called for cooperation and urgency in our efforts to conduct combination trials, and referenced our work to launch the MRF Breakthrough Consortium, a collaborative partnership designed to accelerate the rate that drug combinations are tested.